Day: May 22, 2020

ST. PAUL, Minn. and OAKLAND, Calif., May 22, 2020 (GLOBE NEWSWIRE) — Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), and Nom Nom™, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve as Nom Nom’s central lab for the generation of high quality microbiome data.Nom Nom is dedicated to research and data analysis to enable continued improvement of the health of all pets. The company has published multiple peer-reviewed studies on the pet microbiome (“gut health”) including one of the largest pet microbiome studies to date in which scientists analyzed and characterized the bacteria living in the guts of 238 pets in an effort to better understand how these...

VANCOUVER, British Columbia, May 22, 2020 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCPK: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”), today announced it has appointed Mr. Mark Saxon, as President & CEO of the Company, effective May 25, 2020. Mr. Saxon is an experienced and respected public market executive, with substantial experience in rare earth elements (“REE”) and other critical raw materials. Current President & CEO Don Lay will transition to a strategic advisor role and remain on the board of directors and an officer to support the future growth of the Company.“There is a tremendous and growing opportunity in the REE industry, and we’re excited to attract someone of Mark’s caliber to lead Medallion Resources during this critical phase. He has been an advisor to the Company for several...

BEIJING, May 22, 2020 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (NASDAQ: KC) (“Kingsoft Cloud” or the “Company”), the largest independent cloud service provider in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2020 before the open of U.S. markets on Wednesday, June 3, 2020.Kingsoft Cloud’s management will host an earnings conference call on Wednesday, June 3, 2020 at 8:00 am, U.S. Eastern Time (8:00 pm, Beijing/Hong Kong Time on the same day).Due to the outbreak of COVID-19, operator assisted conference calls are not available at the moment. All participants must preregister online prior to the call to receive the dial-in details.Preregistration InformationParticipants can register for the conference call by navigating to http://apac.directeventreg.com/registration/event/1655977....

IRVINE, Calif. and LUND, Sweden, May 22, 2020 (GLOBE NEWSWIRE) — Clinical Laserthermia Systems AB (publ) (CLS) today announced it is conducting new in-vivo precision laser ablation treatment studies for neuro and prostate using its TRANBERG Thermal Therapy System with Thermoguide thermometry software. The company is also currently preparing its application for 510(k) clearance from the American Food and Drug Administration (FDA) for the U.S. market.Recent dialog between CLS and the FDA has brought about new information. Most notably, the demand for preclinical data is now more extensive than the company initially expected, primarily for products to be used in neuro applications, but also for use in other indications. This quarter, CLS will initiate preclinical studies in neuro and prostate scheduled to last throughout the year.In...

AS Pro Kapital Grupp (hereinafter Pro kapital) hereby informs that the Supervisory Council of Pro Kapital has on 21 May 2020 decided to approve the issue of unsecured, callable, fixed rate non-convertible bonds (hereinafter the Bonds). The Management Board of Pro Kapital is authorized to issue the Bonds on the following main conditions:With the view of exchanging existing Pro Kapital convertible bonds listed in section 4, Pro Kapital shall issue Bonds in the aggregate nominal value of the Bonds up to EUR 10 252 258.80 euros (up to 3 661 521 Bonds);Nominal value of the Bonds will be EUR 2.80;The Bonds will carry interest at a fixed rate, which shall not be higher than 8%, p.a.;The Bonds may be subscribed for only in exchange for the existing Pro Kapital convertible bonds with the following ISIN codes: EE3300104033, EE3300106574, EE3300108711,...

AS Pro Kapital Grupp (edaspidi kui Pro Kapital) teatab käesolevaga, et Pro Kapitali nõukogu otsustas 21. mail 2020 kiita heaks tagamata, ennetähtaegse lunastamise õigusega ja fikseeritud intressimääraga mittekonverteeritavate võlakirjade (edaspidi nimetatud Võlakirjad) emiteerimise. Pro Kapitali juhatus sai volitused emiteerida Võlakirju järgmistel põhitingimustel:Eesmärgiga vahetada punktis 4 loetletud olemasolevaid Pro Kapitali vahetusvõlakirju emiteerib Pro Kapital Võlakirju nominaalväärtuses kokku kuni 10 252 258,80 eurot (kuni 3 661 521 Võlakirja);Võlakirjade nimiväärtus on EUR 2,80;Võlakirjad on fikseeritud intressiga, mis ei ole suurem kui 8% kalendriaastas;Võlakirjade eest on võimalik tasuda vaid Pro Kapitali olemasolevate konverteeritavate võlakirjadega, millel on järgmised ISIN koodid: EE3300104033, EE3300106574, EE3300108711,...

 AS Pro Kapital Grupp (hereinafter Pro kapital) hereby informs that the Supervisory Council of Pro Kapital has on 21 May 2020 decided to approve the issue of unsecured, callable, fixed rate non-convertible bonds (hereinafter the Bonds). The Management Board of Pro Kapital is authorized to issue the Bonds on the following main conditions:With the view of exchanging existing Pro Kapital convertible bonds listed in section 4, Pro Kapital shall issue Bonds in the aggregate nominal value of the Bonds up to EUR 10 252 258.80 euros (up to 3 661 521 Bonds);Nominal value of the Bonds will be EUR 2.80;The Bonds will carry interest at a fixed rate, which shall not be higher than 8%, p.a.;The Bonds may be subscribed for only in exchange for the existing Pro Kapital convertible bonds with the following ISIN codes: EE3300104033, EE3300106574, EE3300108711,...

NEW YORK and LONDON, May 22, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ: TLSA, AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, today announces that it intends to demerge its StemPrintER and SPARE (together “StemPrintER”) genomics-based personalized medicine businesses into a separate company and effect a capital reduction to facilitate the spin-out and listing of StemPrintER as an independent entity. Following the Company’s recent announcement concerning the trial conducted by scientists from the European Institute of Oncology in Milan in collaboration with the Royal Marsden Hospital and Queen Mary University in London on the Company’s stem cell biology-based genomic tool, StemPrintER, for the prediction of disease recurrence...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 22, 2020 (GLOBE NEWSWIRE) — Global Care Capital Corp. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company, ViraxClear, through its joint venture Shanghai Biotechnology Devices Ltd. (“SBD”) has on May 20th, 2020, finalized a Letter Of Intent (LOI) with Phyto Pharma Ltd (“Phyto”), for the supply of 5,000 FDA Registered and CE marked infrared thermometer units (“Thermometers”) for sale in North Africa, with a Purchase Order signed for the value of US$ 125,000 for the 5,000 units.James Foster, CEO of ViraxClear, states that, “The sudden...

Thin Film Electronics ASA (“Thinfilm”) issues this notice on behalf of four existing Officers and Directors.Morten Opstad, Chairman of the Board and primary insider in Thin Film Electronics ASA (the “Company”), has been allocated and subscribed for 1,818,182 shares in the Company at a subscription price per share of NOK 0.11, and 3,636,364 warrants in the Company, pursuant to resolutions of the Extraordinary General Meeting in the Company on 20 May 2020. 1,818,182 warrants have an exercise price of NOK 0.11 per share and will be exercisable at any time from the date of grant until 31 December 2020, while 1,818,182 warrants have an exercise price of NOK 0.25 per share and will be exercisable at any time from the date of grant until 20 August 2021. Following the transaction, Morten Opstad and close associates hold 1,917,518...